Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dharmendra Kumar Yadav

Showing results (31-40 of 136) with videos related to

Pageof 14
Sort By:
Current Issues in Molecular Biology|January 20, 2023
A Clinical Update on SARS-CoV-2: Pathology and Development of Potential InhibitorsDesh Deepak Singh, Ihn Han, Eun-Ha Choi, et al.
Journal of Biomolecular Structure & Dynamics|January 10, 2020
<i>In silico</i> identification of hydantoin derivatives: a novel natural prolyl hydroxylase inhibitorMahesh Kumar Teli, Surendra Kumar, Dharmendra Kumar Yadav, et al.
Journal of Biomolecular Structure & Dynamics|February 20, 2020
Electric-field-induced electroporation and permeation of reactive oxygen species across a skin membraneDharmendra Kumar Yadav, Surendra Kumar, Eun-Ha Choi, et al.
Journal of Cellular Biochemistry|January 7, 2020
Ligand-based pharmacophore modeling and docking studies on vitamin D receptor inhibitorsDharmendra Kumar Yadav, Surendra Kumar, Mahesh Kumar Teli, et al.
Scientific Reports|September 7, 2018
Insight from Molecular dynamic simulation of reactive oxygen species in oxidized skin membraneSurendra Kumar, Dharmendra Kumar Yadav, Eun-Ha Choi, et al.
Computational and Structural Biotechnology Journal|May 24, 2021
CRISPR/Cas9 based genome editing for targeted transcriptional control in triple-negative breast cancerDesh Deepak Singh, Ihn Han, Eun-Ha Choi, et al.
Journal of Cellular Biochemistry|April 19, 2021
In silico identification of prolyl hydroxylase inhibitor by per-residue energy decomposition-based pharmacophore approachMahesh Kumar Teli, Surendra Kumar, Dharmendra Kumar Yadav, et al.
The Indian Journal of Tuberculosis|July 15, 2026
Is respiratory failure in patients of post-tuberculosis COPD less responsive to non-invasive ventilation?Alok Kumar Mishra, Amitabh Das Shukla, Abhishek Singh, et al.
Scientific Reports|May 4, 2025
Exploring bioactive phytoconstituents as USP21 inhibitors for therapeutic development against cancerSaleha Anwar, Mohd Shahnawaz Khan, Dharmendra Kumar Yadav, et al.
Current Issues in Molecular Biology|November 24, 2022
Review of Developments in Combating COVID-19 by Vaccines, Inhibitors, Radiations, and Nonthermal PlasmaIhn Han, Sohail Mumtaz, Sekar Ashokkumar, et al.
Pageof 14

Showing results (31-40 of 136) with videos related to

Sort By:
Pageof 14
Current Issues in Molecular Biology|January 20, 2023
A Clinical Update on SARS-CoV-2: Pathology and Development of Potential InhibitorsDesh Deepak Singh, Ihn Han, Eun-Ha Choi, et al.
Journal of Biomolecular Structure & Dynamics|January 10, 2020
<i>In silico</i> identification of hydantoin derivatives: a novel natural prolyl hydroxylase inhibitorMahesh Kumar Teli, Surendra Kumar, Dharmendra Kumar Yadav, et al.
Journal of Biomolecular Structure & Dynamics|February 20, 2020
Electric-field-induced electroporation and permeation of reactive oxygen species across a skin membraneDharmendra Kumar Yadav, Surendra Kumar, Eun-Ha Choi, et al.
Journal of Cellular Biochemistry|January 7, 2020
Ligand-based pharmacophore modeling and docking studies on vitamin D receptor inhibitorsDharmendra Kumar Yadav, Surendra Kumar, Mahesh Kumar Teli, et al.
Scientific Reports|September 7, 2018
Insight from Molecular dynamic simulation of reactive oxygen species in oxidized skin membraneSurendra Kumar, Dharmendra Kumar Yadav, Eun-Ha Choi, et al.
Computational and Structural Biotechnology Journal|May 24, 2021
CRISPR/Cas9 based genome editing for targeted transcriptional control in triple-negative breast cancerDesh Deepak Singh, Ihn Han, Eun-Ha Choi, et al.
Journal of Cellular Biochemistry|April 19, 2021
In silico identification of prolyl hydroxylase inhibitor by per-residue energy decomposition-based pharmacophore approachMahesh Kumar Teli, Surendra Kumar, Dharmendra Kumar Yadav, et al.
The Indian Journal of Tuberculosis|July 15, 2026
Is respiratory failure in patients of post-tuberculosis COPD less responsive to non-invasive ventilation?Alok Kumar Mishra, Amitabh Das Shukla, Abhishek Singh, et al.
Scientific Reports|May 4, 2025
Exploring bioactive phytoconstituents as USP21 inhibitors for therapeutic development against cancerSaleha Anwar, Mohd Shahnawaz Khan, Dharmendra Kumar Yadav, et al.
Current Issues in Molecular Biology|November 24, 2022
Review of Developments in Combating COVID-19 by Vaccines, Inhibitors, Radiations, and Nonthermal PlasmaIhn Han, Sohail Mumtaz, Sekar Ashokkumar, et al.
Pageof 14